Home » Newsletters » BioWorld Asia

BioWorld Asia

Jan. 14, 1998

View Archived Issues

EU Setting Research Guidelines For Assessment Of 'Bioethics'

Thalassemia Gene Defect Wards Off Malaria, Other Infections

Genset Adds Ceres' Agricultural Genetics To Its Product Arsenal

Soundings Encourage Quadrant's Go-Ahead Of £30M Flotation

NSL Going Public With Drugs From Ant Venom, Allergy Tests

IsoTis Adds $2M For Work In 'Substitution Medicine'

Scientists Find New Parvovirus For Gene Therapy Vectors

Chiroscience Touts Selectivity Of Second-Generation MMP

Elan And Endorex To Establish US$10 Million Joint Venture For Vaccine Development

Trinity Biotech Adds Another FDA Okay To Expanding Line

Britain Opts Out Of Cloning Ban

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...